Surya Chitra

900 total citations · 1 hit paper
44 papers, 648 citations indexed

About

Surya Chitra is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Surya Chitra has authored 44 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Epidemiology and 10 papers in Pharmacology. Recurrent topics in Surya Chitra's work include Antibiotic Resistance in Bacteria (10 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Antibiotic Use and Resistance (8 papers). Surya Chitra is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Antibiotic Use and Resistance (8 papers). Surya Chitra collaborates with scholars based in United States, India and United Kingdom. Surya Chitra's co-authors include Evan Tzanis, Amy Manley, Lynne Garrity-Ryan, Stephen Villano, Paul C. McGovern, Stephen A. Bai, Sébastien Tanaka, Keith A. Rodvold, Karolyn Horn and Mark H. Gotfried and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Surya Chitra

39 papers receiving 622 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

2022 104 citations Surya Chitra et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Surya Chitra United States	13	189	165	157	147	110	44	648
Shinobu Takeda Japan	12	121 0.6×	195 1.2×	168 1.1×	98 0.7×	160 1.5×	26	771
Sonia Gómez Argentina	21	102 0.5×	403 2.4×	97 0.6×	148 1.0×	248 2.3×	59	1.1k
Ganzhu Feng China	18	161 0.9×	152 0.9×	59 0.4×	178 1.2×	271 2.5×	42	932
Yusheng Chen China	16	155 0.8×	238 1.4×	47 0.3×	76 0.5×	327 3.0×	62	719
Fanny Chéreau France	11	141 0.7×	104 0.6×	21 0.1×	41 0.3×	217 2.0×	16	650
Jun Sik Yoon South Korea	14	215 1.1×	105 0.6×	37 0.2×	52 0.4×	273 2.5×	42	764
Yun Xia China	17	131 0.7×	107 0.6×	39 0.2×	128 0.9×	271 2.5×	42	751
Ting Yu China	16	82 0.4×	141 0.9×	38 0.2×	26 0.2×	233 2.1×	69	779
Teng‐Yi Lin Taiwan	16	87 0.5×	80 0.5×	46 0.3×	29 0.2×	144 1.3×	34	589
Harunur Rashid Bangladesh	15	68 0.4×	72 0.4×	27 0.2×	104 0.7×	268 2.4×	44	664

Countries citing papers authored by Surya Chitra

Since Specialization

Citations

This map shows the geographic impact of Surya Chitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surya Chitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surya Chitra more than expected).

Fields of papers citing papers by Surya Chitra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surya Chitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surya Chitra. The network helps show where Surya Chitra may publish in the future.

Co-authorship network of co-authors of Surya Chitra

This figure shows the co-authorship network connecting the top 25 collaborators of Surya Chitra. A scholar is included among the top collaborators of Surya Chitra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surya Chitra. Surya Chitra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winthrop, Kevin, et al.. (2025). A Phase 2, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Omadacycline in Adults With Nontuberculous Mycobacterial Pulmonary Disease (NTM PD) Caused by Mycobacterium Abscessus Complex (MABc). American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3168–A3168.

File, Thomas M., Keith S. Kaye, Kushagra Gupta, et al.. (2025). Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial. EClinicalMedicine. 90. 103656–103656.

Chitra, Surya, et al.. (2024). Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials. Infectious Diseases and Therapy. 13(12). 2637–2648.

Chitra, Surya, et al.. (2023). Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial. Frontiers in Medicine. 10. 1225710–1225710. 5 indexed citations

Moran, Gregory J., Surya Chitra, & Paul C. McGovern. (2022). Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs. Infectious Diseases and Therapy. 11(1). 517–531. 8 indexed citations

Lodise, Thomas P., et al.. (2021). Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for Clostridioides difficile Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective. Antibiotics. 10(10). 1195–1195. 1 indexed citations

Pai, Manjunath P., Mark H. Wilcox, Surya Chitra, & Paul C. McGovern. (2021). Safety and efficacy of omadacycline by body mass index in patients with community-acquired bacterial pneumonia: Subanalysis from a randomized controlled trial. Respiratory Medicine. 184. 106442–106442. 9 indexed citations

Chitra, Surya, et al.. (2021). 767. Incidence of C. difficile infection (CDI) Cases by CDI-Standardized Infection Ratio (SIR) Among Centers for Medicare and Medicaid Services (CMS)-Participating Short-Term Acute Care Hospitals (ACH) Post Implementation of the Hospital-Acquired Condition Reduction Program (HAC-RP). Open Forum Infectious Diseases. 8(Supplement_1). S480–S481. 1 indexed citations

Chitra, Surya, et al.. (2021). Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial. Open Forum Infectious Diseases. 8(10). ofab459–ofab459. 2 indexed citations

10.

Hunt, Thomas L., Evan Tzanis, Stephen A. Bai, et al.. (2020). The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study. European Journal of Drug Metabolism and Pharmacokinetics. 46(1). 85–92. 16 indexed citations

11.

Cornely, Oliver A., Thomas M. File, Lynne Garrity-Ryan, et al.. (2020). Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment. International Journal of Antimicrobial Agents. 57(2). 106263–106263. 6 indexed citations

12.

Overcash, J. Scott, Evan Tzanis, Amy Manley, et al.. (2020). 1687. Omadacycline in Female Adults With Acute Pyelonephritis: Results from a Randomized, Double-Blind, Adaptive Phase 2 Study. Open Forum Infectious Diseases. 7(Supplement_1). S827–S827. 4 indexed citations

13.

Ramírez, Julio A., Evan Tzanis, Robert Noble, et al.. (2019). Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice. Clinical Infectious Diseases. 69(Supplement_1). S33–S39. 10 indexed citations

14.

Opal, Steven M., Thomas M. File, Tom van der Poll, et al.. (2018). 1374. Integrated Safety Summary of Omadacycline: A Novel Aminomethylcycline Antibiotic. Open Forum Infectious Diseases. 5(suppl_1). S421–S421. 4 indexed citations

15.

Salles, Gilles, Nilanjan Ghosh, Izidore S. Lossos, et al.. (2018). Atezolizumab in Combination with Obinutuzumab and Lenalidomide Demonstrates Favorable Activity and Manageable Toxicity in Patients with Relapsed/Refractory Follicular Lymphoma (FL): An Interim Analysis of a Phase Ib/II Trial. Blood. 132(Supplement 1). 1603–1603. 2 indexed citations

16.

Younes, Anas, John M. Burke, Bruce D. Cheson, et al.. (2018). Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Primary Analysis of a Phase I/II Study. Blood. 132(Supplement 1). 2969–2969. 9 indexed citations

17.

Chitra, Surya, et al.. (2016). Risk factors and prevalence, hepatitis B virus and hepatitis C virus among prison inmates, Chennai, India, 2015. International Journal of Infectious Diseases. 53. 90–90. 4 indexed citations

18.

Silverman, Lawrence A., E. Kirk Neely, Gad B. Kletter, et al.. (2015). Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial. The Journal of Clinical Endocrinology & Metabolism. 100(6). 2354–2363. 40 indexed citations

19.

Dobs, Adrian S., Paul Norwood, Susan Potts, Errol Gould, & Surya Chitra. (2013). Testosterone 2% Gel Can Normalize Testosterone Concentrations in Men with Low Testosterone Regardless of Body Mass Index. The Journal of Sexual Medicine. 11(3). 857–864. 5 indexed citations

20.

Bhattacharjee, Rana, Soumik Goswami, Surya Chitra, et al.. (2012). Evolving adrenal insufficiency. Indian Journal of Endocrinology and Metabolism. 16(8). 369–369. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact